AI-generated summary
The authors describe one premature infant with aggressive posterior retinopathy of prematurity who had a favourable result after laser treatment, then developed new retinal neovascularization about ten days after starting oral sildenafil citrate for pulmonary hypertension. The authors report that the neovascularization regressed after the drug was withdrawn, and they suggest clinicians be aware of this possible retinal adverse effect. The report is a single case, so no general conclusion can be drawn.
- Who or what was studied
- One premature infant (female) with aggressive posterior retinopathy of prematurity and pulmonary hypertension
- Limits stated in the abstract
- This is a single case report, so a causal link between sildenafil and the neovascularization cannot be established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.